The Fragile Brain: Stress Vulnerability, Negative Affect and GABAergic Neurocircuits in Psychosis
- 31 May 2019
- journal article
- review article
- Published by Oxford University Press (OUP) in Schizophrenia Bulletin
- Vol. 45 (6) , 1170-1183
Abstract
Persons with schizophrenia exhibit sensitivity to stress and negative affect (NA), both strongly correlated with poor functional outcome. This theoretical review suggests that NA reflects a “fragile brain,” ie, vulnerable to stress, including events not experienced as stressful by healthy individuals. Based on postmortem evidence of altered gamma-aminobutyric acid (GABA) function in parvalbumin positive interneurons (PVI), animal models of PVI abnormalities and neuroimaging data with GABAergic challenge, it is suggested that GABAergic disruptions weaken cortical regions, which leads to stress vulnerability and excessive NA. Neurocircuits that respond to stressful and salient environmental stimuli, such as the hypothalamic-pituitary-adrenal axis and the amygdala, are highly dysregulated in schizophrenia, exhibiting hypo- and hyper-activity. PVI abnormalities in lateral prefrontal cortex and hippocampus have been hypothesized to affect cognitive function and positive symptoms, respectively; in the medial frontal cortex (dorsal anterior cingulate cortex and dorsal medial prefrontal cortex), these abnormalities may lead to vulnerability to stress, NA and dysregulation of stress responsive systems. Given that postmortem PVI disruptions have been identified in other conditions, such as bipolar disorder and autism, stress vulnerability may reflect a transdiagnostic dimension of psychopathology.Keywords
Funding Information
- National Institute of Mental Health (MH101676[SFT], MH086701[SFT], MH108823[IFT], MH082784[VE])
This publication has 206 references indexed in Scilit:
- Excitation, inhibition, local oscillations, or large-scale loops: what causes the symptoms of schizophrenia?Current Opinion in Neurobiology, 2012
- Dopamine system dysregulation by the hippocampus: Implications for the pathophysiology and treatment of schizophreniaNeuropharmacology, 2012
- Meta-Analysis of Functional Neuroimaging Studies of Emotion Perception and Experience in SchizophreniaBiological Psychiatry, 2012
- A Randomized Clinical Trial of MK-0777 for the Treatment of Cognitive Impairments in People with SchizophreniaBiological Psychiatry, 2011
- Functional connectivity of the human amygdala using resting state fMRINeuroImage, 2009
- Functional grouping and cortical–subcortical interactions in emotion: A meta-analysis of neuroimaging studiesNeuroImage, 2008
- Disease-specific alterations in glutamatergic neurotransmission on inhibitory interneurons in the prefrontal cortex in schizophreniaBrain Research, 2008
- What aspects of emotional functioning are impaired in schizophrenia?Schizophrenia Research, 2008
- The burden of depressive symptoms in the long-term treatment of patients with schizophreniaSchizophrenia Research, 2007
- Sequence of information processing for emotions based on the anatomic dialogue between prefrontal cortex and amygdalaNeuroImage, 2007